OKRA raises ambitious target to 6 million predictions in Life Sciences by end of 2020

by Startacus Admin

OKRA continues to meet increased demand and empower the pharma industry with real-time insights amidst Covid-19 uncertainty

 

After the impressive news in June that OKRA had hit its target of 2 million validated predictions at >95% accuracy a full 6 months early, the company has now set its sights on a record-breaking 6 million predictions completed by year end. This means that pharma companies have benefitted from an unparalleled level of support during the most uncertain time in recent memory, using predictions to guide their staff to take the right next step. 

Focussed on Life Sciences, OKRA has seen increased demand for services in guiding those who work across healthcare, including those on the front lines to solve the Covid-19 pandemic with new treatments and vaccines. Consequently, the company has secured multiple new pharmaceutical clients in recent months. As a result, the company is undertaking a major recruitment drive with a goal to increase its Data Science and Engineering teams by 50%.

Dr Loubna Bouarfa, CEO and Founder of OKRA said: 

“OKRA is in a great position to transform healthcare as we know it. During this pandemic, Pharma has realised the need for more effective, personalised interactions. The industry needs constant refresh, and this has to be done dynamically. We can't rely on any data we had 6 months ago. And that’s why we need AI, to navigate the past and predict the future,” 

The company has been developing AI solutions for Life Sciences since the end of 2015 and is known for applying AI to all stages of the drug lifecycle, clinical, medical, market access and commercial.

“Raising our target to 6 million predictions reflects our big expansion as well as our ambition to continue developing the best in class explainable AI systems. We deploy artificial intelligence to support Life Science professionals in their roles, helping them regain confidence, control and power,” added Bouarfa.

It’s impressive to see a company meeting such ambitious targets but most importantly helping so many in the healthcare sector, in these challenging times.

We look forward to seeing where OKRA goes from here!

Subscribe to our newsletter

If you would like to receive our startup themed newsletter, full of the latest startup opportunities, events, news, stories, tips and advice, then sign up here.

• #
• #ai
• #pharma
• #covid

Published on: 2nd October 2020